Cited by 887Immunotherapy and Immune ResponsesAluminum toxicity and tolerance in plants and animalsImmune responses and vaccinations

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Towards an understanding of the adjuvant action of aluminium

Open access

Marrack, Philippa, McKee, Amy S., Munks, Michael W.·2009·Nature Reviews Immunology

DOI 10.1038/nri2510PMC PMC3147301

Open this paper in CoChat — free account

Abstract

The efficacy of vaccines depends on the presence of an adjuvant in conjunction with the antigen. Of these adjuvants, the ones that contain aluminium, which were first discovered empirically in 1926, are currently the most widely used. However, a detailed understanding of their mechanism of action has only started to be revealed. In this Timeline article, we briefly describe the initial discovery of aluminium adjuvants and discuss historically important advances. We also summarize recent progress in the field and discuss their implications and the remaining questions on how these adjuvants work.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nri2510

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.
Mosmann, T. R., Cherwinski, H. M., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,553
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658 · cited 1×
“Related reports have shown that other particulate materials, such as silica, asbestos and MSU crystals, also act through the NLRP3 inflammasome to produce IL-1&beta”
How dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Czopik, A. K., Takeda, K., Akira, S., & Medzhitov, R. M. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,364
Disruption of the murine IL-4 gene blocks Th2 cytokine responses
Köpf, M., Gros, G. S. L., Bachmann, M. F., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,202
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 1,014

Show all 63 references

Research works printed but not linked: 1

Ramon, G. Sur le pouvoir floculant et sur les proprietes immunisantes d'une toxine diphtherique rendue anatoxique. C. R. Hebd. Seances Acad. Sci. 177, 1338–1340 (1923).

Sorted by citations

Items 201–300 of 885

Micrometer-Sized Titanium Particles Can Induce Potent Th2-Type Responses through TLR4-Independent Pathways
Mishra, P. K., Wu, W., Rozo, C. T., Hallab, N. J., Benevenia, J., & Gause, W. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101392 · Cited by 52
Aluminum Hydroxide Adjuvant Differentially Activates the Three Complement Pathways with Major Involvement of the Alternative Pathway
Güven, E., Duus, K., Laursen, I., Højrup, P., & Houen, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074445 · Cited by 52
Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil
Inbar, R., Weiss, R., Tomljenovic, L., Arango, M., Deri, Y., Shaw, C. A., Chapman, J., Blank, M., & Shoenfeld, Y. (2016) · Immunologic Research · doi:10.1007/s12026-016-8826-6 · Cited by 52
Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience
Jensen‐Jarolim, E., Roth‐Walter, F., Jordakieva, G., & Pali‐Schöll, I. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.12.008 · Cited by 51
Design and application of nanoparticles as vaccine adjuvants against human corona virus infection
Mao, L., Chen, Z., Wang, Y., & Chen, C. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111454 · Cited by 56
Trained Innate Immunity and Its Implications for Mucosal Immunity and Inflammation
Hajishengallis, G., Li, X., Mitroulis, I., & Chavakis, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-28524-1_2 · Cited by 55
Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice
Schneider-Ohrum, K., Giles, B. M., Weirback, H. K., Williams, B. L., DeAlmeida, D. R., & Ross, T. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.051 · Cited by 50
IL-33 released by alum is responsible for early cytokine production and has adjuvant properties
Rose, W., Okragly, A. J., Patel, C. N., & Benschop, R. J. (2015) · Scientific Reports · doi:10.1038/srep13146 · Cited by 51
A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects
Ziegler, A., Soldner, C., Lienenklaus, S., Spanier, J., Trittel, S., Riese, P., Kramps, T., Weiß, S., Heidenreich, R., Jasny, E., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601129 · Cited by 49
CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10
Mirotti, L. C., Alberca, R. W., Gomes, E., Rammauro, F., de Araújo, E. F., Calich, V. L. G., & Russo, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00047 · Cited by 49
Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines
Rapaka, R. R., Cross, A. S., & McArthur, M. A. (2021) · Vaccines · doi:10.3390/vaccines9080820 · Cited by 48
Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
Hayashi, M., Aoshi, T., Haseda, Y., Kobiyama, K., Wijaya, E., Nakatsu, N., Igarashi, Y., Standley, D. M., Yamada, H., Honda‐Okubo, Y., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.015 · Cited by 48
Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination
Wang, X., Cao, F., Yan, M., Liu, Y., Zhu, X., Sun, H., & Ma, G. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.11.023 · Cited by 49
Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides
Shinchi, H., Crain, B., Yao, S., Chan, M., Zhang, S. S., Ahmadiiveli, A., Suda, Y., Hayashi, T., Cottam, H. B., & Carson, D. A. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00285 · Cited by 48
Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapy
Bai, S., Jiang, H., Song, Y., Zhu, Y., Qin, M., He, C., Du, G., & Sun, X. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.027 · Cited by 47
The lipid interaction capacity of Sin a 2 and Ara h 1, major mustard and peanut allergens of the cupin superfamily, endorses allergenicity
Angelina, A., Sirvent, S., Palladino, C., Vereda, A., Cuesta‐Herranz, J., Eiwegger, T., Rodrı́guez, R., Breiteneder, H., Villalba, M., & Palomares, Ó. (2016) · Allergy · doi:10.1111/all.12887 · Cited by 47
A computational model to predict the immune system activation by citrus-derived vaccine adjuvants
Pappalardo, F., Fichera, E., Paparone, N., Lombardo, A., Pennisi, M. A., Russo, G. L., Leotta, M., Pappalardo, F., Pedretti, A., Fiore, F. D., et al. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw293 · Cited by 47
Hydroxypropyltrimethyl ammonium chloride chitosan activates RAW 264.7 macrophages through the MAPK and JAK-STAT signaling pathways
Yang, Y. C., Xing, R., Liu, S., Qin, Y., Li, K., Yu, H., & Li, P. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.10.101 · Cited by 48
Overview of vaccine adjuvants
Wu, Z., & Liu, K. (2021) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2021.100103 · Cited by 47
In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools
Antonelli, A. C. B., Almeida, V. P., de Castro, F. D. O. F., Silva, J. M., Pfrimer, I. A. H., Cunha‐Neto, E., Maranhão, A. Q., Brígido, M. M., Resende, R. O., Bocca, A. L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-03990-6 · Cited by 47
Alzheimer's disease vaccine development: A new strategy focusing on immune modulation
Marciani, D. J. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.08.008 · Cited by 45
Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
Senti, G., Moos, S. C. V., & Kündig, T. M. (2013) · Current Treatment Options in Allergy · doi:10.1007/s40521-013-0003-8 · Cited by 46
Quillaja saponin variants with central glycosidic linkage modifications exhibit distinct conformations and adjuvant activities
Walkowicz, W. E., Fernández‐Tejada, A., George, C. M., Corzana, F., Jiménez‐Barbero, J., Ragupathi, G., Tan, D. S., & Gin, D. Y. (2016) · Chemical Science · doi:10.1039/c5sc02978c · Cited by 46
Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants
Masson, J.-D., Crépeaux, G., Authier, F., Exley, C., & Gherardi, R. K. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.12.015 · Cited by 49
Crumpled Aluminum Hydroxide Nanostructures as a Microenvironment Dysregulation Agent for Cancer Treatment
Лернер, М. И., Mikhaylov, G., Tsukanov, A. A., Lozhkomoev, A. S., Gutmanas, E. Y., Gotman, I., Kozak, A., Türk, V., Turk, B., Psakhye, S. G., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01592 · Cited by 46
Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles
Lebre, F., de Lima, M. C. P., Lavelle, E. C., & Borges, O. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.044 · Cited by 47
Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity
Lybaert, L., Vermaelen, K. Y., Geest, B. G. D., & Nuhn, L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.009 · Cited by 46
Mechanisms of Immune Control of Mucosal HSV Infection: A Guide to Rational Vaccine Design
Truong, N. R., Smith, J. B., Sandgren, K. J., & Cunningham, A. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00373 · Cited by 46
Programming of Distinct Chemokine-Dependent and -Independent Search Strategies for Th1 and Th2 Cells Optimizes Function at Inflamed Sites
Gaylo, A. E., Prizant, H., Popović, M., Fernandes, N. R. J., Anderson, C., Chiou, K. K., Bell, H., Schrock, D. C., Schumacher, J. S., Capece, T., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.026 · Cited by 45
Chitosan and chitosan nanoparticles as adjuvant in local Rift Valley Fever inactivated vaccine
El-Sissi, A. F., Mohamed, F. H., Danial, N. M. H., Gaballah, A. Q., & Ali, K. A. K. (2020) · 3 Biotech · doi:10.1007/s13205-020-2076-y · Cited by 46
Enhancing immune responses to a DNA vaccine encoding Toxoplasma gondii GRA14 by calcium phosphate nanoparticles as an adjuvant
Ahmadpour, E., Sarvi, S., Hashemi‐Soteh, M. B., Sharif, M., Rahimi, M. T., Valadan, R., Tehrani, M., Khalilian, A., Montazeri, M., Fasihi‐Ramandi, M., et al. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.03.006 · Cited by 45
Alum's adjuvant action: grease is the word
Mbow, M., Gregorio, E. D., & Ulmer, J. B. (2011) · Nature Medicine · doi:10.1038/nm0411-415 · Cited by 45
A Mn Al double adjuvant nanovaccine to induce strong humoral and cellular immune responses
Qiao, N., Wang, H., Xu, Y., Chang, Y., Xie, M., Bai, S., He, C., Qin, M., Zhong, X., Jiang, M., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.036 · Cited by 46
Adjuvant Activity of Naturally Occurring Monophosphoryl Lipopolysaccharide Preparations from Mucosa-Associated Bacteria
Chilton, P. M., Hadel, D. M., To, T. T., Mitchell, T. C., & Darveau, R. P. (2013) · Infection and Immunity · doi:10.1128/iai.01150-12 · Cited by 44
Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide
Tobias, J., Jasińska, J., Baier, K., Kundi, M., Ede, N. J., Zielinski, C. C., & Wiedermann, U. (2017) · BMC Cancer · doi:10.1186/s12885-017-3098-7 · Cited by 44
Dendritic Mesoporous Silica Nanoparticle Adjuvants Modified with Binuclear Aluminum Complex: Coordination Chemistry Dictates Adjuvanticity
Yang, Y., Tang, J., Song, H., Yang, Y., Gu, Z., Fu, J., Liu, Y., Zhang, M., Qiao, Z., & Yu, C. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202006861 · Cited by 44
Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen
Lynch, H. E., Stewart, S. M., Kepler, T. B., Sempowski, G. D., & Alam, S. M. (2013) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.11.026 · Cited by 41
Comparison of PLA Microparticles and Alum as Adjuvants for H5N1 Influenza Split Vaccine: Adjuvanticity Evaluation and Preliminary Action Mode Analysis
Zhang, W., Wang, L., Liu, Y., Chen, X., Li, J., Yang, T., An, W., Ma, X., Pan, R., & Ma, G. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1224-z · Cited by 43
Developing a Vaccine Against Multiple Psychoactive Targets: A Case Study of Heroin
Stowe, G. N., Schlosburg, J. E., Vendruscolo, L. F., Edwards, S., Misra, K., Schulteis, G., Zakhari, J. S., Koob, G. F., & Janda, K. D. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711799219316 · Cited by 43
Rod-shaped and fluorine-substituted hydroxyapatite free of molecular immunopotentiators stimulates anti-cancer immunity in vivo
Wang, X., Li, X., Ito, A., Watanabe, Y., & Tsuji, N. M. (2016) · Chemical Communications · doi:10.1039/c6cc02848a · Cited by 43
Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice
Akache, B., Stark, F. C., Jia, Y., Deschatelets, L., Dudani, R., Harrison, B. A., Agbayani, G., Williams, D., Jamshidi, M. P., Krishnan, L., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208067 · Cited by 43
Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice
Kar, U. K., Jiang, J., Champion, C. I., Salehi, S., Srivastava, M. K., Sharma, S. P., Rabizadeh, S., Niazi, K., Kickhoefer, V. A., Rome, L. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038553 · Cited by 43
Nanoemulsion adjuvant–driven redirection of TH2 immunity inhibits allergic reactions in murine models of peanut allergy
O’Konek, J. J., Landers, J. J., Janczak, K. W., Goel, R. R., Mondrusov, A. M., Wong, P. T., & Baker, J. R. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.01.042 · Cited by 42
Novel Delivery Routes for Allergy Immunotherapy
Senti, G., & Kündig, T. M. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.006 · Cited by 41
Safety assessment of adjuvanted vaccines: Methodological considerations
Silva, F. T. D., Pasquale, A. D., Yarzábal, J. P., & Garçon, N. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1043501 · Cited by 42
A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults
Jin, X., Newman, M. J., Rosa, S. C. D., Cooper, C. J., Thomas, E. P., Keefer, M. C., Fuchs, J. D., Blattner, W. A., Livingston, B. D., McKinney, D. M., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.060 · Cited by 41
A Comparative Study of Stress-mediated Immunological Functions with the Adjuvanticity of Alum
Wang, Y., Rahman, D., & Lehner, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347179 · Cited by 41
Recent thymic emigrants are tolerized in the absence of inflammation
Friesen, T. J., Ji, Q., & Fink, P. J. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151990 · Cited by 41
Uniform dendrimer-like mesoporous silica nanoparticles as a nano-adjuvant for foot-and-mouth disease virus-like particle vaccine
Liu, Z., Ru, J., Sun, S., Teng, Z., Dong, H., Song, P., Yang, Y., & Guo, H. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb03315c · Cited by 42
Nucleic acids presenting polymer nanomaterials as vaccine adjuvants
Comberlato, A., Paloja, K., & Bastings, M. M. C. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01222b · Cited by 39
Amyloid-β and α-Synuclein Immunotherapy: From Experimental Studies to Clinical Trials
Nimmo, J., Kelly, L., Verma, A. K., Carare, R. O., Nicoll, J. A. R., & Dodart, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.733857 · Cited by 40
Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants
Ljutic, B., Ochs, M. M., Messham, B., Ming, M., Dookie, A., Harper, K., & Ausar, S. F. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.02.038 · Cited by 40
Potent Induction of Antibody-Secreting B Cells by Human Dermal-Derived CD14+ Dendritic Cells Triggered by Dual TLR Ligation
Matthews, K., Chung, N. P. Y., Klasse, P. J., Moore, J. P., & Sanders, R. W. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200601 · Cited by 40
Exploring the Papillomaviral Proteome to Identify Potential Candidates for a Chimeric Vaccine against Cervix Papilloma Using Immunomics and Computational Structural Vaccinology
Kaliamurthi, S., Selvaraj, G., Chinnasamy, S., Wang, Q., Nangraj, A. S., Cho, W. C. S., Gu, K., & Wei, D. (2019) · Viruses · doi:10.3390/v11010063 · Cited by 40
IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine
Bhowmick, S., Ravindran, R., & Ali, N. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-8 · Cited by 40
Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway
Wang, C., Li, H., Zhang, M., Li, X.-L., Yue, L.-T., Zhang, P., Zhao, Y., Wang, S., Duan, R., Li, Y.-B., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0334-4 · Cited by 39
Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity
Li, Z., Zhao, Y., Li, Y., & Chen, X. (2021) · Vaccines · doi:10.3390/vaccines9020075 · Cited by 42
Alpha-D-glucan nanoparticulate adjuvant induces a transient inflammatory response at the injection site and targets antigen to migratory dendritic cells
Lu, F., Mosley, Y. C., Rosales, R. J. R., Carmichael, B. E., Elesela, S., Yao, Y., & HogenEsch, H. (2017) · npj Vaccines · doi:10.1038/s41541-017-0007-7 · Cited by 41
Nanoalum adjuvanted vaccines: small details make a big difference
Raponi, A., Brewer, J. M., Garside, P., & Laera, D. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101544 · Cited by 37
Functional and immunological evaluation of two novel proteins of Leptospira spp.
Fernandes, L. G. V., Vieira, M. L., Alves, I. J., de Morais, Z. M., Vasconcellos, S. A., Romero, E. C., & Nascimento, A. L. T. O. (2013) · Microbiology · doi:10.1099/mic.0.072074-0 · Cited by 38
Advances in Adjuvanted Influenza Vaccines
Shichinohe, S., & Watanabe, T. (2023) · Vaccines · doi:10.3390/vaccines11081391 · Cited by 37
Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective
Liu, D., Liu, L., Li, X., Wang, S., Wu, G., & Che, X. (2024) · Vaccines · doi:10.3390/vaccines12080950 · Cited by 40
Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood
Andersson, N. W., Svalgaard, I. B., Hoffmann, S. S., & Hviid, A. P. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-00997 · Cited by 44
ATP drives eosinophil effector responses through P2 purinergic receptors
Kobayashi, T., Soma, T., Noguchi, T., Nakagome, K., Nakamoto, H., Kita, H., & Nagata, M. (2015) · Allergology International · doi:10.1016/j.alit.2015.04.009 · Cited by 37
Innate sensors that regulate vaccine responses
Georg, P., & Sander, L. E. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.02.006 · Cited by 36
Development of an Inactivated Vaccine against SARS CoV-2
Pavel, S. T. I., Yetişkin, H., Uygut, M. A., Aslan, A. F., Aydın, G., İnan, Ö., Kaplan, B., & Özdarendeli, A. (2021) · Vaccines · doi:10.3390/vaccines9111266 · Cited by 40
The Role of Lipopeptidophosphoglycan in the Immune Response toEntamoeba histolytica
Wong‐Baeza, I., Alcántara‐Hernández, M., Mancilla‐Herrera, I., Itzmel, R.-S., Arriaga‐Pizano, L., Ferat-Osorio, E. A., López-Macías, C. I. R., & Isibasi, A. (2010) · BioMed Research International · doi:10.1155/2010/254521 · Cited by 37
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
Cabral‐Miranda, G., Heath, M. D., Mohsen, M. O., Gomes, A. C., Engeroff, P., Flaxman, A. L., Leoratti, F. M. S., El-Turabi, A., Reyes‐Sandoval, A., Skinner, M. A., et al. (2017) · Vaccines · doi:10.3390/vaccines5020010 · Cited by 37
Micro and nanotechnologies: The little formulations that could
Stiepel, R. T., Duggan, E., Batty, C. J., & Ainslie, K. M. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10421 · Cited by 38
A Rational, Systematic Approach for the Development of Vaccine Formulations
Morefield, G. L. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9261-1 · Cited by 37
Analysis of the immunogenicity and bioactivities of a split influenza A/H7N9 vaccine mixed with MF59 adjuvant in BALB/c mice
Ou, H., Yao, H., Yao, W. Q., Wu, N., Wu, X., Han, C., Cheng, L., Chen, K., Chen, H., & Li, L. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.037 · Cited by 36
Engineering polymeric nanocapsules for an efficient drainage and biodistribution in the lymphatic system
Cordeiro, A. S., Crecente‐Campo, J., Bouzo, B. L., González, S., de la Fuente, M., & Alonso, M. J. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2018.1561886 · Cited by 35
Inflammasomes as Targets for Adjuvants
Ivanov, K., Garanina, E. E., Rizvanov, A. A., & Khaiboullina, S. F. (2020) · Pathogens · doi:10.3390/pathogens9040252 · Cited by 38
Emerging adjuvants for intradermal vaccination
Chen, X. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122559 · Cited by 36
Involvement of CD300a Phosphatidylserine Immunoreceptor in Aluminum Salt Adjuvant–Induced Th2 Responses
Miki, H., Nakahashi-Oda, C., Sumida, T., & Shibuya, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402915 · Cited by 36
Assessment of the adjuvant activity of mesoporous silica nanoparticles in recombinant Mycoplasma hyopneumoniae antigen vaccines
Virginio, V. G., Bandeira, N. C., Leal, F. M. D. A., Lancellotti, M., Zaha, A., & Ferreira, H. B. (2017) · Heliyon · doi:10.1016/j.heliyon.2016.e00225 · Cited by 39
Phytol-derived novel isoprenoid immunostimulants
Chowdhury, R. R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00049 · Cited by 35
Targeting Antigens for Universal Influenza Vaccine Development
Nguyen, Q. T., & Choi, Y. K. (2021) · Viruses · doi:10.3390/v13060973 · Cited by 35
New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies
Marciani, D. J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.015 · Cited by 34
T Cell Costimulation by TNFR Superfamily (TNFRSF)4 and TNFRSF25 in the Context of Vaccination
Schreiber, T. H., Wolf, D., Bodero, M. D., Gonzalez, L. E., & Podack, E. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200597 · Cited by 37
Aluminium based adjuvants and their effects on mitochondria and lysosomes of phagocytosing cells
Ohlsson, L., Exley, C., Darabi, A., Sandén, E., Siesjö, P., & Eriksson, H. (2013) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2013.08.003 · Cited by 36
Development of chitosan–pullulan composite nanoparticles for nasal delivery of vaccines:in vivostudies
Cevher, E., Salomon, S. K., Somavarapu, S., Brocchini, S., & Alpar, H. O. (2015) · Journal of Microencapsulation · doi:10.3109/02652048.2015.1073393 · Cited by 35
Adjuvants and delivery systems for antifungal vaccines: Current state and future developments
Portuondo, D. L., Ferreira, L. S., Urbaczek, A. C., Batista-Duharte, A., & Carlos, I. Z. (2014) · Medical Mycology · doi:10.1093/mmy/myu045 · Cited by 33
Neonatal Vaccination: Challenges and Intervention Strategies
Morris, M. C., & Surendran, N. (2016) · Neonatology · doi:10.1159/000442460 · Cited by 35
AChR-specific immunosuppressive therapy of myasthenia gravis
Luo, J., & Lindstrom, J. M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.011 · Cited by 33
Aluminum as an adjuvant in Crohn’s disease induction
Lerner, A. (2012) · Lupus · doi:10.1177/0961203311430090 · Cited by 33
An approach to local immunotoxicity induced by adjuvanted vaccines
Batista-Duharte, A., Portuondo, D. L., Carlos, I. Z., & Pérez, Ó. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.07.025 · Cited by 33
The Use of Adjuvants for Enhancing Allergen Immunotherapy Efficacy
Chesné, J., Schmidt‐Weber, C. B., & Bieren, J. E. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.009 · Cited by 33
Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies
Aitken, A. S., Roy, D. G., & Bourgeois‐Daigneault, M. (2017) · Biomedicines · doi:10.3390/biomedicines5010003 · Cited by 35
Gold Nanoparticles Coimmobilized with Small Molecule Toll-Like Receptor 7 Ligand and α-Mannose as Adjuvants
Shinchi, H., Yamaguchi, T., Moroishi, T., Yuki, M., Wakao, M., Cottam, H. B., Hayashi, T., Carson, D. A., & Suda, Y. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00560 · Cited by 34
Glycans as Vaccine Antigens and Adjuvants: Immunological Considerations
Zimmermann, S., & Lepenies, B. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2874-3_2 · Cited by 33
Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol
Fernández‐Tejada, A., Chea, E. K., George, C. M., Gardner, J. R., Livingston, P. O., Ragupathi, G., Tan, D. S., & Gin, D. Y. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.09.016 · Cited by 32
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
Egli, A., Santer, D. M., Barakat, K., Zand, M. S., Levin, A., Vollmer, M., Weisser, M., Khanna, N., Kumar, D., Tyrrell, D. L., et al. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13940 · Cited by 34
Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime–protein boost HIV-1 vaccine
Pouliot, K., Buglione‐Corbett, R., Marty-Roix, R., Paquette, S. W. M., West, K., Wang, S., Lu, S., & Lien, E. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.010 · Cited by 34
Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice
Rodriguez, L., Tirado, Y., Reyes, F., Puig, A., Kadir, R., Borrero, R., Fernandez, S., Reyes, G., Álvarez, N., Garcia, M. A., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.077 · Cited by 33
Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine
Sun, H., Wei, C., Liu, B., Jing, H., Feng, Q., Tong, Y., Yang, Y., Yang, L.-Y., Zuo, Q., Zhang, Y., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s91529 · Cited by 32
Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs
Malm, M., Heinimäki, S., Vesikari, T., & Blazevic, V. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12977 · Cited by 32
150 years of the periodic table: New medicines and diagnostic agents
Imberti, C., & Sadler, P. J. (2020) · Advances in inorganic chemistry · doi:10.1016/bs.adioch.2019.11.001 · Cited by 32
Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes
Ozberk, V., Reynolds, S. L., Huo, Y., Calcutt, A., Eskandari, S., Dooley, J., Mills, J.-L. S., Rasmussen, I. S., Dietrich, J., Pandey, M., et al. (2021) · mBio · doi:10.1128/mbio.03537-20 · Cited by 32
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants
Liu, H., Zhou, C., An, J., Song, Y., Yü, P., Li, J., Gu, C., Hu, D., Jiang, Y., Zhang, L., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.10.066 · Cited by 32

Authors: Marrack, P., McKee, A. S., & Munks, M. W.
Affiliations: Howard Hughes Medical Institute (US)
Corresponding author: Marrack, Philippa
ORCID: Marrack, Philippa
McKee, Amy S.
Munks, Michael W.
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2009-04
Volume: 9
Issue: 4
Pages: 287-293
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/nri2510
PMC: PMC3147301
OpenAlex: W1990954596
Cited by: 887
References: 63
Citations by year: 2026: 44 · 2025: 47 · 2024: 57 · 2023: 47 · 2022: 41 · 2021: 67 · 2020: 50 · 2019: 45 · 2018: 49 · 2017: 65 · 2016: 56 · 2015: 72 · 2014: 44 · 2013: 64 · 2012: 49
FWCI: 3.59
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Howard Hughes Medical Institute
National Institute of Allergy and Infectious Diseases (P01AI022295, R37AI018785)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Agricultural and Biological Sciences › Plant Science › Aluminum toxicity and tolerance in plants and animals
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords: alum adjuvant, aluminum salts, vaccine adjuvants, adjuvant mechanisms, vaccine efficacy, immunogenicity
MeSH terms: NLR Family, Pyrin Domain-Containing 3 Protein, Adjuvants, Immunologic, Adsorption, Aluminum, Animals, Antibody Formation, Antigen-Presenting Cells, Antigens, Carrier Proteins, Cytoskeletal Proteins, Humans, Immunity, Cellular, Immunity, Innate, Aluminum Compounds, Models, Immunological, Caspase 1, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Towards an understanding of the adjuvant action of aluminium

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks